HAMP and cardiomyopathy: Hamp−/−/shFxn mice exhibited significantly shorter lifespans, aggravated cardiomyopathy as assessed by echocardiogram, and higher levels of cardiac Gdf15 mRNA (Fig. 6A and C–E).